INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

71,432 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
BM
Bazante Jennifer M.Director
UCBUNITED COMMUNITY BANKS INC
Gift
G—
1,916 sh
Jan 28, 2026Jan 28, 2026
Page 1383 of 1786
← PrevNext →
traded Jan 28, 2026
+0d
SEC Form 4

Evidence

24
HA
Hasija AmitCFO & EVP of Corp. Development
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC Form 4

Evidence

24
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$6.90M
14.6K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

24
ML
Muller LorenzChief Commercial Officer
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC Form 4

Evidence

24
BD
Bharucha DavidChief Medical Officer
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC Form 4

Evidence

24
NE
Nelson Jeffrey EdwardChief Operating Officer
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC Form 4

Evidence

24
SC
Spencer CourtneyChief Experience Officer
LOBLive Oak Bancshares, Inc.
Option exercise
M$190K
14.0K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

24
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$3.72M
7,875 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

24
NE
Nelson Jeffrey EdwardChief Operating Officer
MISTMilestone Pharmaceuticals Inc.
Grant or award
A—
100.0K sh
Dec 12, 2025Jan 28, 2026
traded Dec 12, 2025
+47dSEC Form 4

Evidence

23
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$173K
377 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC Form 4

Evidence

23
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2,851
27 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

23
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$8,207
82 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

23
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3,835
36 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

23
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$3,872
37 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

23
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
127 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

23
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$5,622
55 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

23
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$12K
118 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

23
RR
Reyes Aaron RobertCHIEF FINANCIAL OFFICER
SHOSunstone Hotel Investors, Inc.
Tax withholding
F$255K
28.3K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

23
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$150K
321 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC Form 4

Evidence

23
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1,862
18 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

23
PS
Polmanteer Tamara S.Exec. Vice President & CHRO
CRCrane Co
Tax withholding
F$338K
1,653 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

21
SC
Sagara Kevin C.Director
SRESEMPRA
Grant or award
A—
3,133 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

21
DR
Davies James RChief Financial Officer/FSVP
UNTYUNITY BANCORP INC /NJ/
Grant or award
A—
2,000 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

21
SC
Sagara Kevin C.Director
SRESEMPRA
Grant or award
A—
4,320 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

21
GD
Giles Jeffrey DEVP, Corporate Development
CNMCore & Main, Inc.
Grant or award
A—
4,377 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

21
TJ
Thompson JulietDirector
INDVIndivior Pharmaceuticals, Inc.
Grant or award
A—
3,722 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

21
BG
Bove David GChief Information Officer/SVP
UNTYUNITY BANCORP INC /NJ/
Grant or award
A—
2,000 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

21
IM
Ipsen MikkelSVP, Human Resources
NENoble Corp plc
Option exercise
M—
2,264 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

21
SC
Sharabba Daniel CChief Retail Officer/SVP
UNTYUNITY BANCORP INC /NJ/
Grant or award
A—
2,000 sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

21
SP
Suarez John PeterDirector
EPREPR PROPERTIES
Option exercise
M—
1,564 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

21
RR
Reyes Aaron RobertCHIEF FINANCIAL OFFICER
SHOSunstone Hotel Investors, Inc.
Grant or award
A—
50.9K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

21
MI
Mat IshbiaDirector, President and CEO, 10% Owner
UWMCUWM Holdings Corp
Open-market sale · 10b5-1 plan
SELL$3.68M
632.9K sh
Jan 27, 2026Jan 28, 2026
traded Jan 27, 2026
+1dSEC Form 4

Evidence

21
PS
Polmanteer Tamara S.Exec. Vice President & CHRO
CRCrane Co
Option exercise
M—
3,478 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

20
BM
Bazante Jennifer M.Director
UCBUNITED COMMUNITY BANKS INC
Gift
G—
1,916 sh
Jan 28, 2026Jan 28, 2026
traded Jan 28, 2026
+0dSEC Form 4

Evidence

20
JE
Jewell Curtis ESVP, General Counsel
ESABESAB Corp
Option exercise
M$133K
3,960 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

20
AC
Alting CarolineSVP, Ops. Excellence & Sust
NENoble Corp plc
Tax withholding
F$56K
1,618 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

20
PT
Pinner Jeffrey TsviChief Technology Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$173K
1,600 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

19
BM
Benkowitz MichaelPRESIDENT AND COO
UTHRUNITED THERAPEUTICS Corp
Open-market sale · 10b5-1 plan
SELL$125K
271 sh
Jan 20, 2026Jan 28, 2026
traded Jan 20, 2026
+8dSEC Form 4

Evidence

19
JE
Jewell Curtis ESVP, General Counsel
ESABESAB Corp
Tax withholding
F$303K
2,512 sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence

19
HA
Huska Patricia AnneChief People Officer
GBTGGlobal Business Travel Group, Inc.
Tax withholding
F$816K
114.1K sh
Jan 26, 2026Jan 28, 2026
traded Jan 26, 2026
+2dSEC Form 4

Evidence